ACLA News
-
As Seniors’ Lab Benefits Hang In The Balance, Leading Stakeholder Groups Urge Congress To Pass LAB Act In End-of-Year Legislation
WASHINGTON, D.C.— In a new letter to Congressional leadership, more than 33 stakeholder groups are urging lawmakers to pass commonsense, bipartisan reforms that would take steps to mitigate the ongoing harm facing more than 53 million seniors who depend on vital clinical laboratory services. The letter reinforces the urgent need for Congress to immediately advance H.R. 3584 – The Laboratory Access for Beneficiaries (LAB)Continue Reading »... -
ACLA’s Motion for Summary Judgment in ACLA v. Azar
... -
ACLA Files A Motion for Summary Judgment Against HHS In ACLA v. Azar
Washington, D.C. — Following a favorable decision on a jurisdictional question issued by the U.S. Court of Appeals for the D.C. Circuit, the American Clinical Laboratory Association (ACLA) has filed a motion for summary judgment before the U.S. District Court for the District of Columbia challenging the flawed implementation of the Protecting Access to Medicare Act (PAMA) in the final rule promulgated by the U.S. DepartmentContinue Reading »... -
Op-Ed: If Washington takes a short-sighted view, seniors will pay the price
This week, ACLA President Julie Khani published an op-ed in The Hill, responding to a troubling recent proposal by Roger Klein to disregard private payor data and instead impose a spending cap for some tests. As Khani points out, “Such a plan would further erode PAMA’s clear goal of moving to a market-based system in Medicare and would undermine the assurances of a predictableContinue Reading »... -
New Report Highlights Value of Clinical Labs to U.S. Economy
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today released new economic data highlighting the contributions of clinical laboratories to the economy and the job market in the United States. The findings provide a snapshot of the benefits clinical labs provide to the national economy as well as states and local communities. Clinical laboratories support more than 688,000 jobs in the workforce, bringingContinue Reading »... -
More Than 80 Leading Health Organizations Call on Congress to Modernize Clinical Diagnostic Oversight
Washington, D.C. – As part of a renewed push to advance comprehensive diagnostic reform, more than 80 leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers reiterated the urgent need for Congressional action on a modernized regulatory framework for clinical laboratory diagnostics. Patients have yet to benefit from groundbreaking clinical diagnostics that monitor and support treatment for complex and rareContinue Reading »... -
ACLA Expands Policy, Government Affairs Teams with Joan Kegerize, Liz Thomas
Kegerize to help lead ACLA’s policy work related to reimbursement & scientific affairs; Thomas to support industry’s broader advocacy and federal affairs priorities Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced two new additions to the Association’s policy and advocacy teams. Joan Kegerize, who previously served as a principal consultant for GMBI Consulting, will serve as Vice President of Reimbursement andContinue Reading »... -
ACLA Appellant/Petitioner Brief: American Clinical Laboratory Association v. Alex Azar
... -
ACLA Urges Congressional Leaders to Advance New Regulatory Framework for Diagnostic Tests
In Comments to Congress, ACLA Cites Concerns with the FDA’s New Proposals for Diagnostic Reform Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) calls on Congressional leaders to enact a distinct regulatory framework for diagnostics – a key goal outlined in comments to Reps. Larry Bucshon (R-IN) and Diana DeGette (D-CO), and Sens. Orrin Hatch (R-UT) and Michael Bennet (D-CO). The commentsContinue Reading »... -
Stakeholder Letter on Diagnostic Reform
...
